Paramount PeptidesRetatrutide
Ordered Retatrutide from Paramount Peptides? Mail in a sample (US only) and let us test it for free.
Test my supplyParamount Peptides' Retatrutide profile is mainly held back by one near-threshold purity miss at 99.488%. Later tests recovered, but several passing fills were sizable overfills (+24–27%) and batch IDs are often missing.
We investigated who actually operates Paramount Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Paramount Peptides rows.
Cancel anytime
Ordered Retatrutide from Paramount Peptides? Mail in a sample (US only) and let us test it for free.
Test my supplyAbout Paramount Peptides test results from Finnrick
Paramount Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 65 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Paramount Peptides peptides in this dataset are Semaglutide (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 65 recent tests.
Ordered Retatrutide from Paramount Peptides? Mail in a sample (US only) and let us test it for free.
Test my supply